← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Fundacion Inciensa
San Jose
$101,279,375
Total funding
5
Grants
Funding over time
peak $23.6M · FY2009–25$25M$18.8M$12.5M$6.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$101,279,375 · 5
By mechanism
N01$97,448,765 · 4
N02$3,830,610 · 1
Investigators at Fundacion Inciensa
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
IGF::OT::IGF TASK ORDER 1: ONE-DOSE TRIAL SETUP, ENROLLMENT AND IMMUNIZATION$20,939,852
N01 · FY2017 · CA
IGF::OT::IGF Follow-up and Extended Follow-up of Participants - Option 1$8,733,983
N02 · FY2021 · CA
IGF::OT::IGF Follow-up and Extended Follow-up of Participants - Option 1$8,284,411
N02 · FY2020 · CA
Follow-up and Extended Follow-up of Participants - Option 1$7,761,125
N01 · FY2023 · CA
FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS_ Cures funded$7,688,239
N01 · FY2022 · CA
IGF::OT::IGF Follow-up and Extended Follow-up of Participants - Option 1$6,590,883
N01 · FY2019 · CA
IGF::OT::IGF Follow-up and Extended Follow-up of Participants - Option 1$6,208,277
N01 · FY2018 · CA
HPV TYPE 16 VACCINE TRIAL IN COSTA RICA$4,794,576
N01 · FY2010 · CA
HPV TYPE 16 VACCINE TRIAL IN COSTA RICA$4,236,717
N01 · FY2011 · CA
HPV TYPE 16 VACCINE TRIAL IN COSTA RICA$4,101,779
N01 · FY2009 · CA
IGF::OT::IGF EXIT OF CVT PARTICIPANTS AND PLANNING YEAR FOR ONE DOSE TRIAL$3,830,610
N02 · FY2016 · CA
FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS_ Cures funded$3,125,784
N01 · FY2024 · CA
EXTENSION OF ESCUDDO FOLLOW-UP FROM FIVE YEARS TO 7.5 YEARS (REFERRED TO AS ESCUDDO-7)$3,083,060
N01 · FY2025 · CA
HUMAN PAPILLOMAVIRUS (HPV) TYPE 16 VACCINE TRIAL IN COSTA RICA$2,638,379
N01 · FY2017 · CA
HUMAN PAPILLOMAVIRUS (HPV) TYPE 16 VACCINE TRIAL IN COSTA RICA$2,280,313
N01 · FY2013 · CA
HUMAN PAPILLOMAVIRUS (HPV) TYPE 16 VACCINE TRIAL IN COSTA RICA$1,996,084
N01 · FY2012 · CA
HUMAN PAPILLOMAVIRUS (HPV) TYPE 16 VACCINE TRIAL IN COSTA RICA$1,277,543
N01 · FY2016 · CA
HPV TYPE 16 VACCINE TRIAL IN COSTA RICA$870,317
N01 · FY2012 · CA
Laboratory testing of biospecimens collected from participants of the NCIâs HPV Vaccine studies.$608,967
N01 · FY2024 · CA
Follow-up and Extended Follow-up of Participants - Option 1$566,352
N01 · FY2022 · CA